Genmab A/S (GMAB)
28.20
+0.21
(+0.75%)
USD |
NASDAQ |
May 31, 16:00
28.19
-0.01
(-0.04%)
After-Hours: 20:00
Genmab Market Cap: 18.18B for May 31, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 31, 2024 | 18.18B |
May 30, 2024 | 18.05B |
May 29, 2024 | 18.05B |
May 28, 2024 | 18.06B |
May 24, 2024 | 18.05B |
May 23, 2024 | 18.94B |
May 22, 2024 | 19.24B |
May 21, 2024 | 18.82B |
May 20, 2024 | 19.17B |
May 17, 2024 | 19.35B |
May 16, 2024 | 19.14B |
May 15, 2024 | 19.51B |
May 14, 2024 | 19.06B |
May 13, 2024 | 18.83B |
May 10, 2024 | 18.63B |
May 09, 2024 | 18.61B |
May 08, 2024 | 18.60B |
May 07, 2024 | 18.92B |
May 06, 2024 | 18.75B |
May 03, 2024 | 19.19B |
May 02, 2024 | 17.92B |
May 01, 2024 | 18.59B |
April 30, 2024 | 17.90B |
April 29, 2024 | 18.47B |
April 26, 2024 | 18.20B |
Date | Value |
---|---|
April 25, 2024 | 17.81B |
April 24, 2024 | 18.46B |
April 23, 2024 | 18.52B |
April 22, 2024 | 18.79B |
April 19, 2024 | 18.61B |
April 18, 2024 | 18.41B |
April 17, 2024 | 18.54B |
April 16, 2024 | 19.13B |
April 15, 2024 | 19.18B |
April 12, 2024 | 19.02B |
April 11, 2024 | 19.35B |
April 10, 2024 | 19.49B |
April 09, 2024 | 19.50B |
April 08, 2024 | 19.43B |
April 05, 2024 | 19.36B |
April 04, 2024 | 19.31B |
April 03, 2024 | 19.09B |
April 02, 2024 | 19.52B |
April 01, 2024 | 19.72B |
March 28, 2024 | 19.48B |
March 27, 2024 | 19.95B |
March 26, 2024 | 20.10B |
March 25, 2024 | 19.54B |
March 22, 2024 | 19.50B |
March 21, 2024 | 19.29B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
10.55B
Minimum
Jun 05 2019
31.85B
Maximum
Sep 03 2021
21.96B
Average
23.07B
Median
Sep 28 2023
Market Cap Benchmarks
Ascendis Pharma A/S | 7.718B |
Novo Nordisk A/S | 602.60B |
Galecto Inc | 16.41M |
Evaxion Biotech AS | 19.86M |
IO Biotech Inc | 78.07M |
Market Cap Related Metrics
PE Ratio | 23.37 |
PS Ratio | 7.184 |
PEG Ratio | 2.252 |
Price to Book Value | 3.868 |
Price to Free Cash Flow | 23.76 |
Price | 28.20 |
Earnings Yield | 4.28% |
PEGY Ratio | 2.252 |
Operating PE Ratio | 22.45 |
Normalized PE Ratio | 25.18 |